You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Medtronic
Mallinckrodt
Boehringer Ingelheim
Merck

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

PANHEMATIN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: PANHEMATIN
Patents:124
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for PANHEMATIN
Recent Clinical Trials for PANHEMATIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
The University of Texas Medical Branch, GalvestonN/A
Mayo ClinicPhase 1
H. Lundbeck A/SPhase 2

See all PANHEMATIN clinical trials

Patent Text Search: US Patents for PANHEMATIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for PANHEMATIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122011100046 Germany   Start Trial PRODUCT NAME: EXKRETIERTE SEZERNIERTE PROTEINE (ESP) VON LEISHMANIA INFANTUM; REGISTRATION NO/DATE: EU/2/11/121/001-009 20110314
300495 Netherlands   Start Trial PRODUCT NAME: LEISHMANIA INFANTUM EXCRETED SECRETED PROTEINS (ESP); REGISTRATION NO/DATE: EU/2/11/121/001-009 20110314
91325 Luxembourg   Start Trial PRODUCT NMAE. LUMINITY; REGISTRATION DATE: 20060920
SPC/GB07/031 United Kingdom   Start Trial PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
300267 Netherlands   Start Trial PRODUCT NAME: PERFLUTREN BEVATTENDE LIPIDE-MICROBOLLEN; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
C300495 Netherlands   Start Trial PRODUCT NAME: LEISHMANIA INFANTUM EXCRETED; REGISTRATION NO/DATE: EU/2/11/121/001-009 20110314
2007C/027 Belgium   Start Trial PRODUCT NAME: PERFLUTREN; AUTHORISATION NUMBER AND DATE: EU/1/06/361/001 20060922
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Express Scripts
Mallinckrodt
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.